Thakore-James, Manisha MD

150 Huntington Ave
Boston, MA 02115

Located in the vibrant city of Boston MA Dr. Manisha Thakore-James is a seasoned M.D. specializing in General and Allopathic Medicine. As a medical doctor she brings a wealth of knowledge and experience to her practice offering comprehensive healthcare services to her patients.

With a focus on general medicine Dr. Thakore-James provides expert care and guidance to individuals seeking personalized treatment plans and compassionate medical support. Her dedication to the field of allopathic medicine is evident in her commitment to staying current with the latest advancements and best practices ensuring that her patients receive top-quality care.

Generated from this place's public information

Also at this address

Own this business?
See a problem?

You might also like

Internal medicine practitioners

Lago, Tiffany MD

Located in the bustling city of Boston MA Dr. Tiffany Lago M.D. specializes in General/Allopathic Medicine. As a Medical Doctor with expertise in general healthcare Dr. Lago brings a wealth of knowledge and experience to her practice. Patients seeking comprehensive medical care can trust Dr. Lago's dedication to providing top-notch services in the field of allopathic medicine. With a focus on general health and well-being Dr. Lago's practice offers a holistic approach to patient care in the vibrant city of Boston. Generated from this place's public information
Specialized dental practitioners, Internal medicine practitioners

S & K Dental Group

3
"They are one of the best doctors in Boston. I've seen many dentists in my life, and they're the most professional, skilled and meticulous dentists. When I first started seeing them, I had a few..."
photo of Julia W.
Internal medicine practitioners

CureLab Oncology Inc

CureLab Oncology Inc., based in Boston, MA, is a biotechnology company dedicated to developing innovative anti-cancer biologics aimed at extending the lives of oncology patients. Their lead product, Elenagen, is a plasmid circular DNA encoding gene p62 SQSTM1, which has shown promise in reversing tumor grade, enhancing anti-tumoral immune responses, and mitigating chronic inflammation. The company has completed international Phase I and IIa clinical trials of Elenagen, demonstrating a high degree of safety and clinical benefits for participants. Following these successes, CureLab Oncology is now initiating Phase II clinical trials both outside and within the United States to further assess Elenagen's effectiveness. Generated from the website
United States›Massachusetts›Boston›Thakore-James, Manisha MD

Partial Data by Infogroup (c) 2024. All rights reserved.